Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 10:04 am Purchase |
2020-12-31 | 13G | Purple Biotech Ltd. PPBT |
CVI Investments, Inc. | 67,444 0.800% |
67,444 (New Position) |
Filing History |
| 2021-02-16 10:03 am Sale |
2020-12-31 | 13G | Phio Pharmaceuticals Corp. PHIO |
CVI Investments, Inc. | 2,119 4.000% |
-1,846 (-46.55%) |
Filing History |
| 2021-02-16 10:03 am Purchase |
2020-12-31 | 13G | Alto Ingredients, Inc. ALTO |
CVI Investments, Inc. | 3,798,329 4.900% |
3,798,329 (New Position) |
Filing History |
| 2021-02-16 10:02 am Purchase |
2020-12-31 | 13G | InVivo Therapeutics Holdings Corporation NVIVQ |
CVI Investments, Inc. | 40,748 4.800% |
22,462 (+122.84%) |
Filing History |
| 2021-02-16 10:01 am Purchase |
2020-12-31 | 13G | Intec Pharma Ltd NTEC |
CVI Investments, Inc. | 23,750 2.400% |
23,750 (New Position) |
Filing History |
| 2021-02-16 10:01 am Purchase |
2020-12-31 | 13G | Myomo, Inc. MYO |
CVI Investments, Inc. | 240,639 4.900% |
15,005 (+6.65%) |
Filing History |
| 2021-02-16 10:00 am Sale |
2020-12-31 | 13G | MoSys, Inc. MOSY |
CVI Investments, Inc. | 186,669 4.900% |
-117,831 (-38.70%) |
Filing History |
| 2021-02-16 10:00 am Purchase |
2020-12-31 | 13G | LM Funding America, Inc. LMFA |
CVI Investments, Inc. | 26,961 4.900% |
294 (+1.10%) |
Filing History |
| 2021-02-16 09:59 am Purchase |
2020-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA |
CVI Investments, Inc. | 420 1.300% |
420 (New Position) |
Filing History |
| 2021-02-16 09:59 am Purchase |
2020-12-31 | 13G | Genius Brands International, Inc. GNUS |
CVI Investments, Inc. | 1,346,790 4.900% |
605,121 (+81.59%) |
Filing History |
| 2021-02-16 09:58 am Purchase |
2020-12-31 | 13G | Globus Maritime Limited GLBS |
CVI Investments, Inc. | 158,271 4.900% |
158,271 (New Position) |
Filing History |
| 2021-02-16 09:58 am Purchase |
2020-12-31 | 13G | FuelCell Energy, Inc. FCEL |
CVI Investments, Inc. | 4,306 0.000% |
4,306 (New Position) |
Filing History |
| 2021-02-16 09:57 am Purchase |
2020-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
CVI Investments, Inc. | 1,171 4.900% |
5 (+0.46%) |
Filing History |
| 2021-02-16 09:57 am Purchase |
2020-12-31 | 13G | Castor Maritime Inc. CTRM |
CVI Investments, Inc. | 66,767 4.900% |
66,767 (New Position) |
Filing History |
| 2021-02-16 09:56 am Sale |
2020-12-31 | 13G | Checkpoint Therapeutics, Inc. CKPT |
CVI Investments, Inc. | 63,696 1.000% |
-293,447 (-82.17%) |
Filing History |
| 2021-02-16 09:55 am Purchase |
2020-12-31 | 13G | Nuwellis, Inc. NUWE |
CVI Investments, Inc. | 41 4.900% |
41 (New Position) |
Filing History |
| 2021-02-16 09:55 am Sale |
2020-12-31 | 13G | ContraFect Corporation CFRX |
CVI Investments, Inc. | 18,258 4.900% |
-9,832 (-35.00%) |
Filing History |
| 2021-02-16 09:54 am Sale |
2020-12-31 | 13G | Can-Fite BioPharma Ltd. CANF |
CVI Investments, Inc. | 2,316,165 5.000% |
-610,665 (-20.86%) |
Filing History |
| 2021-02-16 09:54 am Purchase |
2020-12-31 | 13G | Brickell Biotech, Inc. BBI |
CVI Investments, Inc. | 62,459 4.900% |
19,569 (+45.63%) |
Filing History |
| 2021-02-16 09:53 am Sale |
2020-12-31 | 13G | Avinger, Inc. AVGR |
CVI Investments, Inc. | 333 0.100% |
-13,000 (-97.50%) |
Filing History |